Newsbenzinga
Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreak
· Published
Article summary
Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.
An excerpt from the original article.
Comments —
Loading comments…